Bioequivalence and Bioavailability Forum • Sample Size Based on Pharmacodynamic endpoints

Sample Size Based on Pharmacodynamic endpoints [Power / Sample Size]

posted by nobody – 2019-04-05 10:37 (2284 d 14:33 ago) – Posting: # 20124
Views: 4,903

❝ The fact that it is also a royal waste of money is of course only secondary.

Full-blown development mode. Accept it. Tell the sponsor you can't do the trial, if you are not qualified for PD-endpoint testing.

—
Kindest regards, nobody

Complete thread:

Sample Size Based on Pharmacodynamic endpoints sury 2019-04-03 12:28 [Power / Sample Size]
- Sample Size Based on Pharmacodynamic endpoints ElMaestro 2019-04-03 13:22
  - Sample Size Based on Pharmacodynamic endpoints nobody 2019-04-03 13:36
  - Sample Size Based on Pharmacodynamic endpoints sury 2019-04-05 06:36
    - Sample Size Based on Pharmacodynamic endpoints ElMaestro 2019-04-05 08:22
      - Sample Size Based on Pharmacodynamic endpointsnobody 2019-04-05 08:37

Admin contact
23,427 posts in 4,929 threads, 1,679 registered users;
31 visitors (0 registered, 31 guests [including 11 identified bots]).
Forum time: 01:11 CEST (Europe/Vienna)

Many people tend to look at programming styles and languages like religions:
if you belong to one, you cannot belong to others.
But this analogy is another fallacy. Niklaus Wirth

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz